Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
about
Emollients and moisturisers for eczemaHygiene and emollient interventions for maintaining skin integrity in older people in hospital and residential care settingsConsensus Conference on Clinical Management of pediatric Atopic DermatitisThe objective severity assessment of atopic dermatitis (OSAAD) score: validity, reliability and sensitivity in adult patients with atopic dermatitisTmem79/Matt is the matted mouse gene and is a predisposing gene for atopic dermatitis in human subjectsPotential Applications of Phyto-Derived Ceramides in Improving Epidermal Barrier Function.Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators.Skin barrier functionAbnormal skin barrier in the etiopathogenesis of atopic dermatitis.Research statistics in atopic eczema: what disease is this?Immunomodulatory effect of water soluble extract separated from mycelium of Phellinus linteus on experimental atopic dermatitis.[Efficacy of barrier creams in comparison to skin care products in dental laboratory technicians--a controlled trial].Thematic review series: skin lipids. The role of epidermal lipids in cutaneous permeability barrier homeostasis.Guidelines of care for the management of atopic dermatitis: section 2. Management and treatment of atopic dermatitis with topical therapies.Efficacy of combined peroxisome proliferator-activated receptor-α ligand and glucocorticoid therapy in a murine model of atopic dermatitis.The clinical relevance of maintaining the functional integrity of the stratum corneum in both healthy and disease-affected skin.Spot-on skin lipid complex as an adjunct therapy in dogs with atopic dermatitis: an open pilot studyExpression of epidermal CAMP changes in parallel with permeability barrier status.An emerging role for the lipid mediator sphingosine-1-phosphate in mast cell effector function and allergic disease.Guidelines of care for the management of atopic dermatitis: Section 4. Prevention of disease flares and use of adjunctive therapies and approachesStratum corneum maturation. A review of neonatal skin function.New insights into atopic dermatitis.New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.Focal adhesion kinase controls pH-dependent epidermal barrier homeostasis by regulating actin-directed Na+/H+ exchanger 1 plasma membrane localization.Stratum corneum defensive functions: an integrated view.The management of dry skin with topical emollients--recent perspectives.The clinical benefit of moisturizers.Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patientsAtopic dermatitis prevention.Atopic xerosis: employment of noninvasive biophysical instrumentation for the functional analyses of the mildly abnormal stratum corneum and for the efficacy assessment of skin care products.On the effects of topical synthetic pseudoceramides: comparison of possible keratinocyte toxicities provoked by the pseudoceramides, PC104 and BIO391, and natural ceramidesComparison of the Efficacy of Atopalm(®) Multi-Lamellar Emulsion Cream and Physiogel(®) Intensive Cream in Improving Epidermal Permeability Barrier in Sensitive SkinAcceptability and efficacy of an emollient containing ceramide-precursor lipids and moisturizing factors for atopic dermatitis in pediatric patients.Clinical use of a ceramide-based moisturizer for treating dogs with atopic dermatitis.Management of itch in atopic dermatitis.Barrier repair trumps immunology in the pathogenesis and therapy of atopic dermatitisBasis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms"Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis.Co-regulation and interdependence of the mammalian epidermal permeability and antimicrobial barriers.Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.
P2860
Q24186075-2F03D7CD-0CAC-4B7C-B0C7-B46916A9F875Q24187705-1AD8F2AE-23F7-4AEE-BF7C-D460B55D6136Q28071974-4EBFFFE3-A9A8-44AD-9A6D-0F7CB64C6E0DQ28273743-9BFEA932-A7F3-4D97-B8A4-96FAE6C59C37Q28511427-531682CF-F1D7-4DD4-AF15-AF975E622F5CQ30313257-58E68FE8-6448-4620-827D-2EE9D97F5A20Q30494234-D601931C-EB45-46E0-A755-74473978FD3DQ33744906-F85FEBB8-EADB-4509-9DA9-967F80E8743CQ33779047-C9FD1DAE-FB71-4D1B-AA41-CDD3433B2CBCQ34298225-57CE87F7-BE68-4119-9AC1-AFE3B4C8423CQ34417644-F7DF52DB-72DC-47FF-8FE0-1FD9C68F1519Q34468587-3BAB9811-0D72-49E9-9BCC-B91CF4A70D72Q34687966-F06B51AE-8BA1-40EE-B0F4-2006E647D994Q35077866-238FE77D-F600-45B6-BB1E-67E80C0EBDC9Q35167249-EB9EF6B3-88CF-4B10-8219-C909FAC6C1D9Q35220452-46166D43-8B7A-49DB-ABFD-85AB02BF59B0Q35239179-34AEE81F-7B66-49B8-9842-75086AA6EF9FQ35349520-97E6D169-B66B-410B-B178-72FD1E950B1BQ35545433-5BB66768-610C-493F-A4EB-234A1705E095Q35603170-E9FB89C8-5B2F-4D91-8298-C93FC0A7B0DAQ35672070-9B97A80D-3FBB-47C3-BC85-54A62F8948BFQ35678332-61DD3BBA-98C0-4D94-8CD6-B02920AA199CQ35838744-E1B7777F-B32C-4E0C-9434-847A80268DD4Q35855529-9AF59F79-C344-47FE-B372-342837010C52Q36228049-0BE4C170-C4E0-49B9-BADD-15AA6C457F7CQ36272156-1B7293BA-F73D-4823-A734-3A615774E91AQ36305888-D3967133-7A81-4125-9836-C1B643A49023Q36387203-653C7D8E-14D1-447B-92F5-76E459448631Q36466794-A46EDECF-C480-490B-851D-03198D4753C9Q36686119-27B1340B-0659-497B-AB62-EBA8CF15C69DQ36696383-58C9CFBB-7AD4-4191-974E-B3F6825992FBQ36703830-E559F2FD-870A-46E7-9B73-DB6330E6E39BQ36767733-0CC6AB0E-3280-433B-AAAC-9B4E43053248Q36958942-E302BBC4-0342-4E0F-AFF8-EC27500CA8F4Q36991444-A86E8CBD-09AD-4CB9-BD1A-DFD938F29618Q37037943-1C076540-D334-4847-B7C0-BA4B690BEF20Q37105441-C3802B1B-9D4B-42AA-ADC0-C787C3AD8A48Q37137538-05B9ED2F-1FF9-4556-9193-7C6C0519E08FQ37164058-582DB13F-4E8D-4090-8492-70630AB70229Q37164077-238396FE-CAA5-4325-BBB5-EF76157AE18B
P2860
Ceramide-dominant barrier repair lipids alleviate childhood atopic dermatitis: changes in barrier function provide a sensitive indicator of disease activity.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Ceramide-dominant barrier repa ...... indicator of disease activity.
@en
Ceramide-dominant barrier repa ...... indicator of disease activity.
@nl
type
label
Ceramide-dominant barrier repa ...... indicator of disease activity.
@en
Ceramide-dominant barrier repa ...... indicator of disease activity.
@nl
prefLabel
Ceramide-dominant barrier repa ...... indicator of disease activity.
@en
Ceramide-dominant barrier repa ...... indicator of disease activity.
@nl
P2093
P356
P1476
Ceramide-dominant barrier repa ...... indicator of disease activity.
@en
P2093
Ashley J Fowler
Joachim W Fluhr
Mary L Williams
Mary Y Sheu
Peter M Elias
Sarah L Chamlin
P304
P356
10.1067/MJD.2002.124617
P407
P577
2002-08-01T00:00:00Z